Ticker Sage

Company file · ALAB

Astera Labs

Singapore was Astera Labs' fastest-growing region in FY2025, up 853.3%

Revenue rose 115.1% to $853M in FY2025, from $396M in FY2024. Net income was $219M, against a net loss of $83M a year earlier. Singapore was the largest region, at 32% of revenue.

Key facts

Astera Labs (Nasdaq: ALAB) closed fiscal 2025 on Dec 31, 2025 with revenue of $853M, up 115.1% from a year before; net income came to $219M, compared with −$83M. Its newest quarterly report covers the three months to Sep 30, 2026: revenue of $585M, up 153.7% on the same stretch of the prior year, and net income of $183M. Broken down by region, Singapore led with 32% of fiscal 2025 revenue. Sources: 10-K for fiscal 2025 (filed Feb 20, 2026) and 10-Q for the quarter ended Sep 30, 2026 (filed Nov 4, 2026).

Revenue$853MFY2025 · +115.1% vs FY2024
Net income$219MFY2025 · vs −$83M in FY2024
Operating cash flow$319MFY2025 · +133.6% vs FY2024
Cash & equivalents$209Mat Sep 30, 2026 · +24.9% vs FY2025 end
Diluted shares180MFY2025 avg · +36.8% vs FY2024
Revenue and net income, three fiscal yearsBy fiscal year, $bn
RevenueNet income
Revenue and net income by fiscal yearRevenue FY2023: $116M0.12Net income FY2023: −$26M−0.03FY2023Revenue FY2024: $396M0.40Net income FY2024: −$83M−0.08FY2024Revenue FY2025: $853M0.85Net income FY2025: $219M0.22FY2025Data: Ticker Sage, from SEC EDGAR · tickersage.com

Source: 10-K FY2025, filed Feb 20, 2026

Quarterly revenue: fiscal 2026 vs a year earlierFiscal Q1–Q3, $bn (each quarter from that quarter's 10-Q)
FY2025FY2026
Quarterly revenue, fiscal 2026 vs 2025FY2025 Q1: $159M0.16FY2026 Q1: $308M0.31Q1FY2025 Q2: $192M0.19FY2026 Q2: $392M0.39Q2FY2025 Q3: $231M0.23FY2026 Q3: $585M0.58Q3Data: Ticker Sage, from SEC EDGAR · tickersage.com

Source: 10-Q filed May 6, 2026 · 10-Q filed Aug 5, 2026 · 10-Q filed Nov 4, 2026

How it makes money

FY2025 total by categorySingapore: $277M (32%)China: $256M (30%)Taiwan: $247M (29%)Non-US: $44M (5%)United States: $27M (3%)$853MFY2025 totalData: Ticker Sage, from SEC EDGARtickersage.com

By region, FY2025

  • LineAmountSharevs FY2024
  • Singapore$277M32%+853.3%
  • China$256M30%+252.6%
  • Taiwan$247M29%−8.3%
  • Non-US$44M5%+232.9%
  • United States$27M3%+142.8%

Source: 10-K FY2025, XBRL breakdown

By region in FY2025: Singapore (32%), China (30%), Taiwan (29%) and Non-US (5%), as shares of total revenue. Total revenue was $853M.

By region: three-year mixShare of the total each fiscal year
SingaporeChinaTaiwanNon-USUnited States

Source: 10-K FY2025

Learn more: Revenue vs. net income · Gross, operating and net margin

What changed last quarter

How the quarter compared with a year earlier

Comparing Q3 2026 (Jul to Sep 2026) compared with Q3 2025 (Jul to Sep 2025)

Each pair of bars shows the dollar amount for both quarters. Longer bar, more money. Bars in a group share one scale.

Q3 2026Q3 2025

Company

Revenue
$585M Q3 2026
$231M Q3 2025
153.7% increase
Net income
$183M Q3 2026
$91M Q3 2025
100.8% increase

Source: Astera Labs 10-Q for the quarter ended Sep 30, 2026, filed Nov 4, 2026

By region

Singapore
$310M Q3 2026
$95M Q3 2025
228.2% increase
China
$147M Q3 2026
$77M Q3 2025
91.1% increase
Taiwan
$87M Q3 2026
$38M Q3 2025
130.8% increase
Non-US
$35M Q3 2026
$8M Q3 2025
355.2% increase
United States
$6M Q3 2026
$14M Q3 2025
56.9% decrease

Source: Astera Labs 10-Q for the quarter ended Sep 30, 2026, filed Nov 4, 2026

  • Cash & equivalents $209M at Sep 30, 2026, vs $168M at FY2025 end.
  • Operating cash flow, first 9 months of fiscal 2026: $341M vs $224M a year earlier.

The bull case and the bear case

The bull case

The bear case

  • Diluted shares rose 36.8% in FY2025, which spreads profit across more shares. 10-K, FY2025
  • Taiwan revenue fell 8.3% in FY2025 to $247M. 10-K, FY2025
  • The company's own risk factors are in Item 1A of its 10-K. Risks common in this industry include chip cycles; customer concentration; export rules and trade. 10-K, Item 1A

What optimists and skeptics tend to point to, each tied to a filing. Ticker Sage doesn't pick a side, and neither list is a reason to buy or sell.

What the company does

Astera Labs is in the semiconductors industry, part of the information technology sector. The SEC files it under Semiconductors & Related Devices.

The full description of Astera Labs' business is in Item 1 of its 10-K, linked below. This page shows its revenue by region.

Its fiscal year ends in December; the latest, FY2025, ended Dec 31, 2025.

Source: 10-K, Item 1 Business

Risks common in this industry

These are general risks for companies in the semiconductors industry. They are not a summary of Astera Labs’s own risk factors; for those, read Item 1A of its latest 10-K, linked below.

  1. Chip cyclesDemand for chips swings between shortages and gluts, and orders can be cut quickly.
  2. Customer concentrationA few large customers can account for much of sales.
  3. Export rules and tradeExport controls and tariffs can limit sales to some customers or countries.
  4. Manufacturing supplyIt depends on outside factories and suppliers, and disruptions can delay products.
  5. Competition and design winsCustomers pick suppliers product by product, so losing a design can cost years of sales.

Source: 10-K, Item 1A Risk Factors (the company's own list, in the company's words)

Three years of key numbers

Every number links to its filing; hover for the XBRL tag. A dash means the number isn't cleanly available, and we don't estimate it.

US$FY2023FY2024FY2025
Revenue$116M$396M$853M
Net income−$26M−$83M$219M
Operating cash flow−$13M$137M$319M
Cash & equivalents (year end)$45M$80M$168M
Diluted shares37M131M180M
  • Revenue: Total revenue for the fiscal year, as the company reports it on its income statement.
  • Net income: Net income attributable to the company's shareholders, after all costs, interest and taxes.
  • Operating cash flow: Cash the business brought in from its day-to-day operations during the year (cash flow statement).
  • Cash & equivalents: Cash and short-term investments that count as cash equivalents on the balance sheet. Excludes longer-dated marketable securities.
  • Diluted shares: Weighted average shares outstanding for the year, including the effect of options and stock awards.

Learn more: How to read an income statement · Earnings per share, basic and diluted · Free cash flow · How to read a balance sheet · Growth rate calculator · P/E calculator · Market cap calculator · Free cash flow calculator · Return on equity and assets calculator

Explainers for this page

Guides to terms this file uses, with real numbers from filings.

About these numbers

    What we left out

    • Total debt: the company's filing data doesn't carry a consistent debt total for the years shown, so it isn't shown.

    Recent filings

    FormFiledPeriod
    10-QNov 4, 2026Sep 30, 2026
    10-QAug 5, 2026Jun 30, 2026
    10-QMay 6, 2026Mar 31, 2026
    DEF 14AApr 23, 2026Jun 4, 2026
    10-KFeb 20, 2026Dec 31, 2025

    What's in this filing

    The quotes below come from Item 1 (Business) of the Form 10-K Astera Labs filed on Feb 20, 2026, its annual report for the fiscal year ended Dec 31, 2025.

    The latest quarterly report in the table above is the Form 10-Q filed Nov 4, 2026 for the quarter ended Sep 30, 2026.

    A 10-K has audited annual financial statements and the company's own description of its business and risks; a 10-Q has unaudited quarterly statements.

    Building on years of experience with a singular focus on addressing connectivity challenges in data-centric systems, we have developed and deployed our leading Intelligent Connectivity Platform built from the ground up for cloud and AI infrastructure.

    Source: Form 10-K, Item 1 (Business), filed Feb 20, 2026

    Our Intelligent Connectivity Platform comprises of semiconductor-based, high-speed, mixed-signal connectivity products that integrate a matrix of microcontrollers and sensors, and COSMOS, our software suite, which is embedded in our connectivity products and integrated into our customers’ systems.

    Source: Form 10-K, Item 1 (Business), filed Feb 20, 2026

    Short excerpts quoted from the filing. The full document is on SEC.gov.

    Learn more: 10-K vs. 10-Q vs. 8-K · Form 4 insider filings · Fiscal years and quarters

    Common questions about Astera Labs

    How does Astera Labs make money?

    Fiscal 2025 revenue: $853M. By region in FY2025: Singapore (32%), China (30%), Taiwan (29%) and Non-US (5%), as shares of total revenue. Total revenue was $853M. Source: 10-K for fiscal 2025, filed Feb 20, 2026.

    What was Astera Labs's revenue in fiscal 2025?

    $853M, up 115.1% from fiscal 2024 ($396M). The year ended Dec 31, 2025; for fiscal 2023 the figure was $116M. Source: 10-K for fiscal 2025, filed Feb 20, 2026.

    Is Astera Labs profitable?

    Net income was $219M in fiscal 2025 (compared with −$83M; fiscal 2024 was −$83M). That counts as a GAAP profit. The latest quarter, ended Sep 30, 2026: net income was $183M. The page's About these numbers section explains what is included. Source: 10-K for fiscal 2025, filed Feb 20, 2026.

    What did Astera Labs report in its latest quarterly filing?

    For the three months to Sep 30, 2026: revenue $585M (up 153.7% from $231M) and net income $183M (up 100.8% from $91M). Source: 10-Q for the quarter ended Sep 30, 2026, filed Nov 4, 2026.

    What are the main risks Astera Labs faces?

    Astera Labs's own risk factors are in Item 1A of its 10-K for fiscal 2025, filed Feb 20, 2026. Risks that are common among companies in the semiconductors industry include Chip cycles; customer concentration; export rules and trade; manufacturing supply; competition and design wins. The first: Demand for chips swings between shortages and gluts, and orders can be cut quickly. Source: 10-K, Item 1A Risk Factors.

    Where do these Astera Labs numbers come from?

    The 10-K filed Feb 20, 2026 (fiscal 2025) and the 10-Q filed Nov 4, 2026 (quarter ended Sep 30, 2026), as published in the SEC's XBRL data. Click any number to open the filing it came from. Methodology explains how fiscal years and missing numbers are handled.

    Tracked funds that report owning Astera Labs

    From each fund’s latest Form 13F, which is filed up to 45 days after quarter end and lists long positions in US-listed stocks only. A listing here is a fact about a filing, not a view on the stock. What a 13F does and doesn’t show.

    Disclosures

    Editor holdings in ALAB
    The editor holds no position in Astera Labs (ALAB). As of Nov 11, 2026.
    Trading rule
    The editor does not buy or sell ALAB from 3 days before to 3 days after this page is published or substantively updated.
    Compensation
    Nobody paid for this page. No affiliate links on this page.
    Sources
    The company's SEC filings, linked next to each number or, for charts, in the source line under them.
    Last updated
    Nov 20, 2026

    General education, the same for every reader. Not a recommendation to buy, sell or hold ALAB, and it doesn't consider your situation.

    Compare with peers

    CompanyFiscal yearRevenueRevenue growthNet income
    Astera LabsALABFY2025$853M+115.1%$219M
    NvidiaNVDAFY2026$215.9B+65.5%$120.1B
    BroadcomAVGOFY2025$63.9B+23.9%$23.1B
    MicronMUFY2026$133.2B+256.3%$85.0B
    AMDFY2025$34.6B+34.3%$4.3B

    Each row is that company’s latest fiscal year from its own 10-K, using its own revenue and net income lines. Fiscal years end in different months, and line definitions differ (banks, insurers and oil companies count revenue differently), so this is a rough side-by-side, not a like-for-like comparison.

    More company files

    New to filings? Learn has explainers built on real filings and Tools has calculators. Methodology & Disclosures covers where every number comes from.